These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adverse drug reactions: the need for detection and control. Cluff LE Am J Epidemiol; 1971 Nov; 94(5):405-8. PubMed ID: 5120538 [No Abstract] [Full Text] [Related]
3. Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance. Feinstein AR Clin Pharmacol Ther; 1974 Jul; 16(1):110-23. PubMed ID: 4843239 [No Abstract] [Full Text] [Related]
4. The promise of pharmacoepidemiology. Strom BL Annu Rev Pharmacol Toxicol; 1987; 27():71-86. PubMed ID: 3555321 [No Abstract] [Full Text] [Related]
6. Report of the Seventh European Symposium on Clinical Pharmacological Evaluation in Drug control. Deidesheim, 14--17 November 1978. Eur J Clin Pharmacol; 1979 Apr; 15(3):199-209. PubMed ID: 37092 [No Abstract] [Full Text] [Related]
7. Computer analysis of epidemiologic data on effect of drugs on hospital patients. Slone D; Gaetano LF; Lipworth L; Shapiro S; Lewis GP; Jick H Public Health Rep (1896); 1969 Jan; 84(1):39-52. PubMed ID: 4974707 [No Abstract] [Full Text] [Related]
8. Epidemiologic methods in occupational health research. Hernberg S Work Environ Health; 1974; 11(2):59-68. PubMed ID: 4456892 [No Abstract] [Full Text] [Related]
9. Case-control studies in the evaluation of drug-induced illness. Jick H; Vessey MP Am J Epidemiol; 1978 Jan; 107(1):1-7. PubMed ID: 623085 [No Abstract] [Full Text] [Related]
10. Frequency of adverse drug reactions. DeBoer A Br J Clin Pharmacol; 1993 Jul; 36(1):89-91. PubMed ID: 8373719 [No Abstract] [Full Text] [Related]
11. Screening for adverse drug reactions. Bulpitt CJ Br J Hosp Med; 1977 Oct; 18(4):329, 333-4. PubMed ID: 912156 [No Abstract] [Full Text] [Related]
12. Secondary data analysis--a new approach to nursing research. McArt EW; McDougal LW Image J Nurs Sch; 1985; 17(2):54-7. PubMed ID: 3846565 [No Abstract] [Full Text] [Related]
13. How study of geographic epidemiology of disease can help in detection of adverse drug reactions. Stolley PD Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):679-82. PubMed ID: 1269208 [TBL] [Abstract][Full Text] [Related]
14. Adverse drug reaction monitoring. The practicalities. Edwards IR Med Toxicol Adverse Drug Exp; 1987; 2(6):405-10. PubMed ID: 3431427 [No Abstract] [Full Text] [Related]
15. Comment on: "Desideratum for evidence-based epidemiology". Hennessy S; Leonard CE Drug Saf; 2015 Jan; 38(1):101-3. PubMed ID: 25511911 [No Abstract] [Full Text] [Related]
16. [Maternal mortality in Central America. The basis for national programs on epidemiologic surveillance]. Kestler E Rev Latinoam Perinatol; 1989; 9(4):167-77. PubMed ID: 12316763 [TBL] [Abstract][Full Text] [Related]
17. Perinatal epidemiologic research with vital statistics data: validity is the essential quality. Ananth CV Am J Obstet Gynecol; 2005 Jul; 193(1):5-6. PubMed ID: 16021051 [No Abstract] [Full Text] [Related]
18. Authors' reply to Hennessy and Leonard's comment on "Desideratum for evidence-based epidemiology". Overhage JM; Ryan PB; Schuemie MJ; Stang PE Drug Saf; 2015 Jan; 38(1):105-7. PubMed ID: 25511912 [No Abstract] [Full Text] [Related]
19. The method of expected number of deaths, 1786-1886-1986. Keiding N Int Stat Rev; 1987 Apr; 55(1):1-20. PubMed ID: 12179583 [TBL] [Abstract][Full Text] [Related]
20. Monitoring adverse reactions to drugs: toward a therapeutic audit. Wade OL; Beeley L Int J Health Serv; 1974; 4(1):109-23. PubMed ID: 4597989 [No Abstract] [Full Text] [Related] [Next] [New Search]